Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.

Journal article

Nicum S. et al, (2013), Journal of clinical oncology, 31, TPS5615 - TPS5615

Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.

Journal article

Nicum S. et al, (2013), Journal of clinical oncology, 31

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

Journal article

Kerr DJ. et al, (2007), N engl j med, 357, 360 - 369